▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3369 by analyst upside · 2026-09-27
BLCO
Bausch + Lomb Corporation
Healthcare · Market Cap $6B · P/E 0x
ANALYST PRICE TARGET
+12.9%
implied upside to consensus target
Current Price $16.86
Consensus Target $19.04
Bull Target $24.0
Bear Target $16.0
Analysts Covering 13
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
5
Hold
6
Sell
1
52-Week Low $13.77
52-Week High $18.91
YTD Return +1.7%
FUNDAMENTALS
Market Cap $6B
P/E Ratio (TTM) N/A
Forward P/E 15.2x
EPS (TTM) $-0.48
PEG Ratio 0.89
Dividend Yield N/A
Revenue (TTM) $5.3B
Profit Margin -3.2%
52-WEEK RANGE
52-Week Low $13.77
52-Week High $18.91
Current Price $16.86
Bear Target $16.0
Bull Target $24.0
● Now $16.86 ● Target $19.04
TRADING DATA
Avg Volume 400K
YTD Return +1.7%
Analyst Count 13
Consensus Hold
Upside to Target +12.9%
Last Updated 2026-09-27

ANALYST SUMMARY

Bausch + Lomb Corporation (BLCO) is currently trading at $16.86 with a Wall Street consensus price target of $19.04, implying potential upside of 12.9% over the next 12 months. 13 analysts currently cover BLCO, with a consensus rating of Hold - 46% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $24.0, while the most cautious has a target of $16.0.

BLCO operates in the Healthcare sector with a market capitalisation of $6B. The stock is up 1.7% year-to-date and is currently trading near the upper end of its 52-week range of $13.77 – $18.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for BLCO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Needham reit
Hold → Hold 2026-09-15 20% win rate (5 calls)
Leerink Partners ● Initiated
Outperform 2026-09-09 29% win rate (7 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-08-28 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-08-03 31% win rate (48 calls)
UBS - Reiterated
Buy → Buy 2026-07-30 33% win rate (6 calls)
UBS ● Initiated
Buy 2026-07-28 33% win rate (6 calls)
Citigroup - Reiterated
Buy → Buy 2026-07-08 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-07-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
48
out of 100
Coverage depth
20/30
Consensus clarity
21/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →